Skip to main content
. Author manuscript; available in PMC: 2017 Aug 14.
Published in final edited form as: Nanoscale. 2016 Jul 14;8(30):14411–14419. doi: 10.1039/c6nr04091h

Fig. 5.

Fig. 5

Drug loading and characterization of ultra-small hybrid nanoparticles. (a) Drug loading quantification of hybrid nanoparticles fabricated at increasing docetaxel input to PLGA weight ratios (n = 3; mean ± SD). (b) Cumulative release profile of docetaxel-loaded ultra-small hybrid nanoparticles with 2 wt% docetaxel loading over the course of 72 hours in 1X PBS (n = 3; mean ± SD). (c) Cell viability of KB cells treated with either docetaxel-loaded ultra-small hybrid nanoparticles or Taxotere for 72 hours (n = 3; mean ± SD). Samples were normalized according to lysed cell and untreated controls.